JP2022534724A5 - - Google Patents
Info
- Publication number
- JP2022534724A5 JP2022534724A5 JP2021570319A JP2021570319A JP2022534724A5 JP 2022534724 A5 JP2022534724 A5 JP 2022534724A5 JP 2021570319 A JP2021570319 A JP 2021570319A JP 2021570319 A JP2021570319 A JP 2021570319A JP 2022534724 A5 JP2022534724 A5 JP 2022534724A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962856514P | 2019-06-03 | 2019-06-03 | |
| US62/856,514 | 2019-06-03 | ||
| US202063013427P | 2020-04-21 | 2020-04-21 | |
| US63/013,427 | 2020-04-21 | ||
| PCT/US2020/035841 WO2020247440A1 (en) | 2019-06-03 | 2020-06-03 | Use of prg4 to treat cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022534724A JP2022534724A (ja) | 2022-08-03 |
| JPWO2020247440A5 JPWO2020247440A5 (https=) | 2023-06-07 |
| JP2022534724A5 true JP2022534724A5 (https=) | 2023-06-07 |
Family
ID=73652433
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021570319A Pending JP2022534724A (ja) | 2019-06-03 | 2020-06-03 | がんを治療するためのｐｒｇ４の使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220332839A1 (https=) |
| EP (1) | EP3976085A4 (https=) |
| JP (1) | JP2022534724A (https=) |
| CN (1) | CN114173805A (https=) |
| WO (1) | WO2020247440A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT202000022636A1 (it) * | 2020-09-25 | 2022-03-25 | Ente Ospedaliero Specializzato In Gastroenterologia Istituto Nazionale Di Ricovero E Cura A Caratter | “terapia di combinazione di sorafenib e/o regorafenib con la proteina ricombinante umana proteoglicano-4 per il trattamento dell'epatocarcinoma” |
| KR102763607B1 (ko) * | 2021-10-05 | 2025-02-07 | 주식회사 인게니움테라퓨틱스 | 자연살해 세포의 활성 향상용 조성물 |
| CN115125207B (zh) * | 2022-08-01 | 2023-05-02 | 威海见生生物技术有限公司 | 一种诱导干细胞体外定向分化的方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015060935A1 (en) * | 2013-10-22 | 2015-04-30 | Lubris, Llc | Control of rheological properties of mixed hyaluronate/lubricin solutions |
| EP3074022B1 (en) * | 2013-11-26 | 2022-03-30 | Lubris LLC | Compositions and methods for inhibiting intercellular interactions |
| RU2017129880A (ru) * | 2015-01-26 | 2019-03-04 | ЛУБРИС ЭлЭлСи | Применение prg4 в качестве противовоспалительного средства |
-
2020
- 2020-06-03 JP JP2021570319A patent/JP2022534724A/ja active Pending
- 2020-06-03 EP EP20818641.1A patent/EP3976085A4/en not_active Withdrawn
- 2020-06-03 WO PCT/US2020/035841 patent/WO2020247440A1/en not_active Ceased
- 2020-06-03 CN CN202080049571.8A patent/CN114173805A/zh active Pending
- 2020-06-03 US US17/596,066 patent/US20220332839A1/en not_active Abandoned